Sinotherapeutics (SH:688247) Ge Long Hui·2025-12-25 13:29Core Viewpoint - XuanTai Pharmaceutical (688247.SH) announced a restricted stock incentive plan for 2025, aiming to grant up to 6.23 million shares, representing approximately 1.37% of the company's total share capital at the time of the announcement [1] Summary by Categories Incentive Plan Details - The plan proposes an initial grant of up to 4.99 million shares, accounting for about 80.06% of the total grant and approximately 1.10% of the company's total share capital [1] - A reserve of 1.24 million shares is included, which represents 19.94% of the total grant and about 0.27% of the company's total share capital [1] Stock Ownership Limits - As of the announcement date, the total number of shares involved in all effective stock incentive plans does not exceed 10.00% of the company's total share capital [1] - No individual incentive recipient can receive more than 1.00% of the company's total share capital through the stock incentive plan during its effective period [1]